Loading…
S. 4327119th CongressIn committeeLatest action Apr 16, 2026Decoded by AI · checked against the record
Official title: Securing America’s Drug Supply from Communist China Act
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
This bill would block the FDA from approving drugs from companies tied to the Chinese government, party, or military.
55-second read · 4 questions answered below
This bill would require the FDA to review drug applications and check whether the company behind them has financial or organizational ties to the Chinese government, Communist Party, or military. Companies found to have those ties would be blocked from getting drug approvals, and their already-approved drugs could be turned away and destroyed at the border. A company could avoid the ban if it proves it cut those ties or sells its drug licenses to an unrelated company within 180 days, and drugs could still enter if blocking them would cause a shortage.
This bill primarily affects pharmaceutical companies with ties to China and the U.S. agencies that handle drug approvals and border enforcement. American patients and pharmacies that rely on drugs made or owned by Chinese-linked companies could also be affected.
If passed, some drugs currently available in the United States could be blocked from entering the country or lose their approval status. Patients and pharmacies depending on those drugs could face reduced access, especially if a shortage exception does not apply.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
Latest action: — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.